Research Article

CT Combined with Multiparameter MRI in Differentiating Pathological Subtypes of Non-Small-Cell Lung Cancer before Surgery

Table 1

Comparison of indicators between the two groups.

FeaturesTotal casesLUAD (n = 130)LUSC (n = 156)X2

Gender (%)
Male167 (58.4)60 (46.2)107 (68.6)14.691≤0.001
Female119 (41.6)70 (53.8)49 (31.4)
Age (%)
<65 year old87 (30.4)43 (33.1)44 (28.2)0.7950.373
≥65 year old199 (69.6)87 (66.9)112 (71.8)
Smoking (n, %)
No112 (39.2)60 (46.2)52 (33.3)4.8920.027
Yes174 (60.8)70 (53.8)104 (66.7)
Location (%)
Superior lobe of the left lung57 (19.9)29 (22.3)28 (17.9)4.1460.387
Inferior lobe of the left lung58 (20.3)20 (15.4)38 (24.4)
Superior lobe of the right lung64 (22.4)30 (23.1)34 (21.8)
Middle lobe of the right lung60 (21.0)27 (20.8)33 (21.2)
Inferior lobe of the right lung47 (16.4)24 (18.5)23 (14.7)
Tumor size (%)
<3 cm183 (64.0)94 (72.3)89 (57.1)7.1620.007
≥3 cm103 (36.0)36 (27.7)67 (42.9)
Tumor staging (%)
Stages I-II160 (55.9)77 (59.2)83 (53.2)1.0450.307
Stages III-IV126 (44.1)53 (40.8)73 (46.8)
Tissue differentiation degree (%)
Low and middle186 (65.0)79 (60.8)107 (68.6)1.9070.167
High100 (35.0)51 (39.2)49 (31.4)
Lymphatic metastasis (%)
No220 (76.9)105 (80.8)115 (73.7)1.9860.159
Yes66 (23.1)25 (19.2)41 (26.3)
Tumor morphology (%)
Nodule180 (62.9)94 (72.3)86 (55.1)8.9720.003
Mass106 (37.1)36 (27.7)70 (44.9)
Marginal lobulation (%)
No100 (35.0)60 (46.2)40 (25.6)13.121≤0.001
Yes186 (65.0)70 (53.8)116 (74.4)
Marginal burrs (%)
No138 (48.3)54 (41.5)84 (53.8)4.3020.038
Yes148 (51.7)76 (58.5)72 (46.2)
Bronchial truncation sign (%)
No112 (39.2)63 (48.5)49 (31.4)8.6530.003
Yes174 (60.8)67 (51.5)107 (68.6)
Vascular convergence sign (%)
No156 (54.5)59 (45.4)97 (62.2)8.0670.005
Yes130 (45.5)71 (54.6)59 (37.8)

Note. LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.